These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7481353)

  • 21. Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapy.
    Buse JB
    Diabetes Care; 1999 Apr; 22 Suppl 3():C65-70. PubMed ID: 10189565
    [No Abstract]   [Full Text] [Related]  

  • 22. [Practice of antidiabetic therapy in Hungary].
    Hankó BZ; Reszegi CA; Kumli P; Vincze Z
    Acta Pharm Hung; 2005; 75(2):77-86. PubMed ID: 16318232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral agent therapy in the treatment of type 2 diabetes.
    Feinglos MN; Bethel MA
    Diabetes Care; 1999 Apr; 22 Suppl 3():C61-4. PubMed ID: 10189564
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type II diabetes: insulin versus oral agents.
    Chalmers TC
    N Engl J Med; 1986 Nov; 315(19):1233-4. PubMed ID: 3531868
    [No Abstract]   [Full Text] [Related]  

  • 26. [Oral antidiabetic agents for the general practitioner].
    Siegmund T
    MMW Fortschr Med; 2009 Apr; 151(14):86, 88-91; quiz 92. PubMed ID: 19504847
    [No Abstract]   [Full Text] [Related]  

  • 27. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes.
    Tanenberg RJ
    Curr Med Res Opin; 2004 Apr; 20(4):541-53. PubMed ID: 15119992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exenatide (Byetta) for type 2 diabetes.
    Med Lett Drugs Ther; 2005 Jun; 47(1210):45-6. PubMed ID: 15933616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin initiation in Type 2 diabetes.
    Page S
    Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antidiabetic agents and renal insufficiency].
    Robles NR; Blanco J
    Nefrologia; 2002; 22(4):325-8. PubMed ID: 12369123
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of type 2 diabetes mellitus with oral antihyperglycaemic therapy.
    Desai A; Tandon N
    Natl Med J India; 2007; 20(4):192-8. PubMed ID: 18085125
    [No Abstract]   [Full Text] [Related]  

  • 32. Troglitazone for non-insulin-dependent diabetes mellitus.
    Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
    [No Abstract]   [Full Text] [Related]  

  • 33. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Better metabolic control with patient-focused insulin administration].
    Med Monatsschr Pharm; 2005 Oct; 28(10):366. PubMed ID: 16245457
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulin monotherapy vs. combination therapy.
    Ebell MH
    Am Fam Physician; 2005 Mar; 71(5):899. PubMed ID: 15768618
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes.
    Westphal SA; Palumbo PJ
    Arch Intern Med; 2003 Aug 11-25; 163(15):1783-5; discussion 1785. PubMed ID: 12912711
    [No Abstract]   [Full Text] [Related]  

  • 37. [Modern approaches to pharmacotherapy of diabetes mellitus type II].
    Kovel'man IR; Tochilkin AI; Beliaeva NF; Gorodetskiĭ VK; Kniazhev VA; Tkachenko SB; Semenov LL; Semenova NV
    Vopr Med Khim; 2002; 48(4):337-52. PubMed ID: 12506608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical review of oral antihyperglycemic agents for type 2 diabetes mellitus.
    Koski RR
    Diabetes Educ; 2006; 32(6):869-76. PubMed ID: 17102154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The stepwise approach to the management of type 2 diabetes.
    Warren RE
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S3-8. PubMed ID: 15315864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral antidiabetics, pacifiers for doctor and patient].
    Erkelens DW
    Ned Tijdschr Geneeskd; 1983 Dec; 127(52):2380-1. PubMed ID: 6656939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.